The ACC begins this Saturday in Washington, DC. Here’s a preview of some of the most highly-anticipated late-breaking clinical trials. On Saturday morning at the opening session the world will finally learn more about the failure of Symplicity HTN-3, the Medtronic trial of renal denervation…. … Click here to read the entire post on Forbes. …
American College of Cardiology Announces Late-Breaking Clinical Trials
January 31, 2014 by Leave a Comment
The American College of Cardiology announced the lineup of late-breaking clinical trials for its upcoming annual meeting in Washington, DC. The opening session will include the most eagerly anticipated trials– the main results of Symplicity HTN-3 and the comparison of Corevalve and surgery in high risk patients. Subsequent sessions will include several phase 3 trials…
L.A. Confidential: Preview Of AHA Scientific Sessions 2012
October 29, 2012 by Leave a Comment
The American Heart Association scientific sessions, which start next weekend in Los Angeles, will be bigger than ever, with 853 separate sessions– 111 more than last year– and 27 late-breaking clinical trials– 6 more than last year. Elliott Antman, chair of the scientific sessions program committee, provided a preview of some of the highlights of this…
Recent Comments